Sizzling breakthrough for 3D meat

A 4oz steak has been ‘lab-grown’ using a digital design file. Israeli firm MeaTech 3D Ltd. cultivated the bio-printed steak using real fat and muscle cells. The cells were produced using an advanced process that...

Shaping the science of oncology

Dr Fiona McLaughlin is the new Chief Scientific Officer of Avacta’s Therapeutics Division. She talks to Karen Southern about her mission to develop first and best-in-class cancer drugs. From the day that Dr McLaughlin –...

HOPE ON THE HORIZON FOR ALZHEIMER’S TREATMENT

Dr Susan Kohlhaas Director of Research at Alzheimer’s Research UK People with dementia have been disproportionately affected by the COVID-19 pandemic. In fact, according to the ONS, a quarter of people who have died from COVID-19...

Opening new pathways for bioprocessing

A pivotal link between industry and academia, Teesside University’s £22m National Horizons Centre (NHC) opened last September with two very clear objectives. One is to drive research into bioprocessing, an often-overlooked subject through which life...

90 years since Sir Alexander Fleming’s penicillin discovery changed antibiotic treatment

“My name is Sarah Whitlow and my paternal grandfather was Sir Alexander Fleming, who discovered penicillin. I have worked as a practice nurse at the Swan Surgery in Bury St Edmunds, Suffolk, since 1990,...

WEAPONISING THE FIGHT AGAINST ANTIBIOTIC RESISTANCE

Could faecal transplants be an effective weapon in the fight back against antibiotic resistance? A research team at Guy’s and St Thomas’ NHS Foundation Trust intends to find out, once and for all. By HELEN...

Blood oxygen levels could explain why memory loss is an early symptom of Alzheimer’s

The findings demonstrate how the brain’s memory centre operates at a ‘watershed’ making it especially vulnerable to damage Study suggests increasing blood flow in the hippocampus might be really effective at preventing...

Acesis breaks new ground with novel therapy solution to low testosterone

For the first time in over 70 years, a new testosterone replacement therapy has been unveiled. Dr Vassilios Papadopoulos and Dr Costas Karatzas, co-founders of Acesis BioMed, explain how their ‘first-in-class’ peptide therapeutics could...

Biosimilars set to make significant UK impact

Biosimilar medicines - equivalent biological products which have no meaningful differences from the original or reference product in terms of quality, safety or efficacy - are playing an important role in providing choice for...

Simplicity is all

In this issue of BioScience Today, Ellen Rossiter speaks to Professor Kawal Rhode about his work in the realm of biomedical engineering, his inspiration, motivation and why simplicity is all. “Way back in school, we...

Tackling the trillion dollar Alzheimer’s disease

It’s almost impossible to conceive the complexity that lies ahead in the challenge to address Alzheimer’s disease. But, picture standing in front of an old mansion house, completely overgrown with ivy, trees, and shrubs....

Artificial Neural Networks working with Image Guided Therapies to improve heart disease treatment

By Rashed Karim Research Fellow at King’s College London School of Biomedical Engineering and Imaging Sciences It’s exciting to envisage that future treatments for cardiovascular disease will be supported by intelligent systems and devices. At the...

What makes a spinout?

Universities carry out research into some of the most fundamental questions about life and the world around us, with researchers utilising specialist facilities and equipment to investigate and advance human knowledge.  This doesn’t happen overnight,...

Genome sequencing reveals how salmonella carves out a niche in pork production

Variants of concern (VOCs) and variants of interest (VOIs) have become familiar terms due to the current pandemic, but variants of familiar pathogens such as salmonella also present a threat to human and animal...

A golden era for blood cancer treatments

It’s an exciting time in blood cancer research. As we deepen our understanding of the biology of blood cancer, researchers are developing better treatments than ever before, and we’re even beginning to talk about...

Putting the diverse into neurodiversity

The global Institute Of Neurodiversity ION has launched its UK chapter. The Institute aims to give a global voice to all neurodiverse groups, and ensure neurodivergent individuals are understood, represented, and valued equally in society. Currently, 1 in...